Trials / Completed
CompletedNCT00913887
To Demonstrate the Relative Bioavailability of Diclofenac Sodium 75 mg Enteric-Coated Tablets Under Non-Fasting Conditions
A Relative Bioavailability Study of Diclofenac Sodium 75 mg Enteric-Coated Tablets Under Non-Fasting Conditions
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 18 (actual)
- Sponsor
- Sandoz · Industry
- Sex
- Male
- Age
- 18 Years – 40 Years
- Healthy volunteers
- Accepted
Summary
To demonstrate the relative bioavailability of Diclofenac Sodium 75 mg enteric-coated tablets under non-fasting conditions.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Diclofenac Sodium 75 mg Tablets Under Fasting Conditions (Geneva Pharmaceutical) | |
| DRUG | Diclofenac Sodium 75 mg Tablets Under Fed Conditions (Geneva Pharmaceutical) | |
| DRUG | Voltaren 75 mg Tablets Under Fed Conditions (Geigy Pharmaceuticals) |
Timeline
- Start date
- 1994-04-01
- Primary completion
- 1994-05-01
- Completion
- 1994-05-01
- First posted
- 2009-06-04
- Last updated
- 2017-03-28
Source: ClinicalTrials.gov record NCT00913887. Inclusion in this directory is not an endorsement.